Murine research protocols using 510mg/kg body weight demonstrate measurable senescent cell reduction within 57 days post-administration, with effects plateauing above 10mg/kg without additional benefit
Decreased levels of Prevotellaceae correlate with decreased mucin production, which, along with the changes in Akkermansia abundance, can contribute to increased intestinal permeability
Technical Characteristics Compound name: BPC-157 Full designation: Body Protection Compound-157 Type: Synthetic peptide Form: Lyophilized powder Purity: 98% Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or diagnostic use Each batch is tested to ensure identity, purity, and consistency, ensuring reliability in scientific research applications
Pick one or two measurable steps to take
10 GLP-1 clinics in Aurora are currently accepting new patients